Accelevation Holdings Corp. Completes $540M IPO at $18/Share; Selling Stockholders Cash Out $360M
ACCV is trading near its 52-week low of $15.46 (5.1% above the low).
Summary
Accelevation Holdings Corp. completed its $540M IPO at $18/share on October 1, 2026. The company raised $180M from primary shares while selling stockholders received $360M. The filing also establishes a dual-class structure with Olympus Partners retaining board control.
Key Events · Financing and Capital Events · ACCV
-
IPO Closed at $18/Share
30 million Class A shares delivered October 1, 2026 at $18.00 per share. Company sold 10M shares for $180M gross; selling stockholders sold 20M shares for $360M gross.
-
Selling Stockholders Take Majority of Proceeds
Accelevation Cash Pubco Holdings LP and Accelevation Investment Holdings LLC (Olympus Partners affiliates) sold 20M of the 30M firm shares — two-thirds of IPO proceeds went to insiders, not the company.
-
Dual-Class Structure Established
Company issued 116,965,529 Class B shares to Investment Holdings. Class B shares carry one vote each and are exchangeable for Class A shares, giving Olympus Partners majority voting control.
-
Board Appointed with Olympus Control
Seven directors appointed September 29, 2026: Manu Bettegowda, Matt Bujor, Robert Morris, Paul Donahue, Howard Heckes, Ginger Jones, and Martin Durkin. Director Nomination Agreement gives Olympus the right to nominate 100% of non-founder directors while holding ≥40% of original ownership.
Analysis · ACCV · Manufacturing
Accelevation Holdings Corp. closed its initial public offering on October 1, 2026, delivering 30 million Class A shares at $18.00 per share. The company raised $180 million gross from its 10 million primary shares, while existing investors (Olympus Partners affiliates) sold 20 million shares for $360 million — meaning two-thirds of the IPO proceeds went to insiders, not the company. The company also issued 116.97 million Class B shares to Investment Holdings, establishing a dual-class structure where Olympus retains majority voting control through the Director Nomination Agreement. Seven directors were appointed, all affiliated with or nominated by Olympus. The 2026 Omnibus Incentive Plan authorizes 17.89 million shares for future equity awards, representing potential additional dilution. This filing finalizes the IPO terms and reveals the full governance and capital structure post-listing.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 35.7% of the 1024 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ACCV was trading at $16.25 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $2B. The 52-week trading range was $15.46 to $18.10. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.